D

David Maag

Goethe University Frankfurt

Publishes on PARP inhibition in cancer therapy, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology. 125 papers and 7.6k citations.

125Publications

7.6kTotal Citations

PARP inhibition in cancer therapy Advanced Breast Cancer Therapies Cancer Treatment and Pharmacology Glioma Diagnosis and Treatment RNA and protein synthesis mechanisms

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

Shane Crotty, David Maag, Jamie J. Arnold et al.|Nature Medicine|2000

Cited by 817

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

Sibylle Loibl, Joyce O’Shaughnessy, Michael Untch et al.|The Lancet Oncology|2018

Cited by 766

Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain

Anutosh Chakraborty, Michael A. Koldobskiy, Nicholas T. Bello et al.|Cell|2010

Cited by 364Open Access

The Eukaryotic Translation Initiation Factors eIF1 and eIF1A Induce an Open Conformation of the 40S Ribosome

Lori A. Passmore, T.M. Schmeing, David Maag et al.|Molecular Cell|2007

Cited by 332Open Access

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

Véronique Dièras, Hyo S. Han, Bella Kaufman et al.|The Lancet Oncology|2020

Cited by 319Open Access